cladribine has been researched along with Diathesis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Drake, D; Fitzgerald-Bocarsly, P; Hoffman, M; Janson, D; Rai, KR; Sawitsky, A; Shah, K; Shodell, M; Siegal, FP | 1 |
Bosly, A; Delannoy, A; Ferrant, A; Filleul, B; Martiat, P; Michaux, JL; Mineur, P; Montfort, L; Straetmans, N; Van Den Neste, E; Vandercam, B | 1 |
2 other study(ies) available for cladribine and Diathesis
Article | Year |
---|---|
Impaired interferon alpha response in hairy cell leukemia is corrected by therapy with 2-chloro-2'-deoxyadenosine: implications for susceptibility to opportunistic infections.
Topics: Adult; Aged; Cladribine; Disease Susceptibility; Female; Humans; Interferon-alpha; Leukemia, Hairy Cell; Leukocytes, Mononuclear; Lymphocyte Activation; Male; Middle Aged; Opportunistic Infections; Remission Induction; Splenectomy; T-Lymphocyte Subsets | 1994 |
Infectious complications after 2-chlorodeoxyadenosine therapy.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Agents; Cladribine; Cohort Studies; Disease Susceptibility; Female; Fever; Hematologic Diseases; Herpesviridae Infections; Humans; Immunologic Deficiency Syndromes; Incidence; Infections; Leukemia, Hairy Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Leukocyte Count; Lymphoma, Non-Hodgkin; Male; Middle Aged; Retrospective Studies; Risk Factors; Waldenstrom Macroglobulinemia | 1996 |